New York is pursuing a sweeping legal action against five major chemical manufacturers over their role in contaminating the state’s water with toxic substances called PFAS, or “forever chemicals.” On July 9, 2026, the state filed a 74-page complaint in New York State Supreme Court in Albany County naming 3M Company, DuPont de Nemours, EIDP Inc., The Chemours Company, and Corteva Inc. as defendants. The lawsuit alleges that these companies knowingly manufactured and sold consumer products containing PFAS for approximately 50 years while understanding the substances posed serious health and environmental risks they concealed from the public.
The contamination has become inescapable across New York. In Newburgh, New York, a 2025 study of 244 residents found that every single participant tested had PFAS in their bloodstream; nearly half exceeded the 20 nanogram-per-liter threshold that raises health concerns. This widespread human exposure reflects a broader environmental crisis: roughly half of New York’s public water systems now contain PFAS, with approximately 250 systems exceeding the state and federal drinking water standards. The state has already awarded $365 million in grants for cleanup efforts between 2018 and 2024, yet the financial and public health burden continues to mount.
Table of Contents
- What the Lawsuit Alleges and What New York Is Seeking
- Understanding PFAS and Why They Persist in the Environment
- The Scope of Water Contamination Across New York State
- Financial Impact and Prior Legal Settlements
- Evidence of Knowledge and Concealment
- Public Health Warnings and Medical Concerns
- Court Remedies and Long-Term Implications
What the Lawsuit Alleges and What New York Is Seeking
The complaint filed by New York’s attorney General charges the defendants with multiple violations including public nuisance, strict products liability for failure to warn consumers, and breaches of New York General Business Law and Executive Law. At the heart of the allegations is a charge of conscious deception: the companies allegedly knew of PFAS dangers for decades but continued selling products containing these chemicals without informing consumers or the public. The suit points to a particularly damning historical claim that DuPont observed birth defects in the babies of its own workers during the 1980s and suppressed the study rather than disclosing the findings.
New York is seeking court orders that would require the defendants to fund comprehensive environmental cleanup efforts statewide, a measure necessary given that 68 percent of groundwater wells sampled near inactive landfills contain PFAS at or above state action levels. Beyond cleanup costs, the state wants mandatory warning labels on any products containing PFAS, financial damages and restitution, penalties, and a prohibition preventing the companies from selling products with harmful PFAS levels without adequate consumer warnings. These remedies address both past harm and future prevention, reflecting New York’s determination to stop the ongoing sale of contaminated products.
Understanding PFAS and Why They Persist in the Environment
PFAS are synthetic chemicals used in hundreds of consumer and industrial products, from non-stick cookware coatings to water-resistant textiles and firefighting foam. The chemicals earned the nickname “forever chemicals” because they do not naturally break down in the environment or in the human body—they persist indefinitely, accumulating over time. This persistence means that PFAS contamination from products sold decades ago continues to pose exposure risks today, and every new product containing PFAS adds to the overall burden.
The state’s environmental data reveals the depth of PFAS saturation in New York soils. PFOS, one category of PFAS, was detected in 97 percent of surface soil samples tested, while PFOA, another type, appeared in 76.5 percent of rural background soil samples where industrial activity was minimal. These high detection rates in undeveloped areas indicate that PFAS has become a widespread environmental contaminant rather than a localized industrial problem. The limitation of current cleanup efforts is important to acknowledge: even with $32 to $54 million in minimum annual spending on safe drinking water infrastructure, New York has not reversed the trend of increasing PFAS detection in public systems.
The Scope of Water Contamination Across New York State
The public water system contamination problem is both extensive and measurable. Approximately 50 percent of New York’s public water systems have tested positive for PFAS, and around 250 of those systems exceed the maximum contaminant levels established by the state and federal government. This means that millions of New Yorkers drawing water from their taps face potential ongoing exposure to these chemicals. Unlike contamination that can be quickly remedied through single cleanup events, PFAS in water supplies requires sustained intervention because new contamination can arise from sources ranging from landfills to manufacturing facilities to consumer product disposal.
A concrete example of the human health dimension emerged in the Newburgh drinking water crisis. When researchers tested 244 residents from this Hudson Valley community in August 2025, they found that 100 percent of participants had measurable PFAS in their blood serum. Among that group, 47 percent had blood PFAS concentrations exceeding 20 nanograms per liter, a level that health scientists have linked to potential immune system effects and other health concerns. The Newburgh case illustrates that in some regions, PFAS exposure is not a theoretical risk but an established reality affecting entire communities.
Financial Impact and Prior Legal Settlements
The financial costs of addressing PFAS contamination in New York are substantial and have only grown as awareness of the problem has expanded. The state’s Department of Environmental Conservation and Department of Health have already committed $365 million in grants between 2018 and 2024 for PFAS-related cleanup projects. Looking forward, maintaining safe drinking water in the face of PFAS contamination will require a minimum of $32 to $54 million annually, a recurring cost that represents a tradeoff: these resources diverted to PFAS remediation are not available for other infrastructure needs. The chemical industry’s prior settlement history suggests New York’s lawsuit is not without precedent.
In 2023, 3M reached a settlement agreement valued at $10.8 billion related to PFAS contamination, one of the largest environmental settlements in U.S. history. DuPont separately settled with public water systems for $1.2 billion. These settlements, while substantial, do not fully cover the costs borne by affected communities, nor do they prevent ongoing exposure from products still in use or newly manufactured. The amounts reflect the judicial system’s recognition of serious wrongdoing but also highlight how litigation often lags years or decades behind the initial harm.
Evidence of Knowledge and Concealment
A critical element of New York’s lawsuit is the allegation that defendants possessed knowledge of PFAS dangers far earlier than they disclosed or acted upon them. The complaint specifically alleges that companies manufactured and sold PFAS-containing products while knowing of health and environmental risks for approximately 50 years. This extended timeline of alleged knowledge while continuing sales forms the basis for claims of negligence and breach of duty to consumers and the public. The lawsuit places particular emphasis on DuPont’s alleged burial of a study showing birth defects in workers’ babies during the 1980s, a charge that if proven suggests intentional concealment rather than mere oversight.
This historical evidence strategy is important to understand because it counters any defense based on ignorance or good faith mistakes. Companies cannot claim they did not know about risks if internal studies documented those risks decades ago. However, a limitation in litigation strategy is that proving knowledge requires access to internal corporate documents, and defendants often fight to keep such evidence confidential or to limit its admission in court. The 74-page complaint represents prosecutors’ initial summary of allegations, but the actual discovery process and trial could reveal far more extensive evidence of what the companies knew and when.
Public Health Warnings and Medical Concerns
Health authorities have raised concerns about PFAS exposure at levels well below dramatic emergency thresholds, which is what makes the contamination particularly insidious. The exposure documented in Newburgh residents, where nearly half had PFAS blood serum levels above 20 nanograms per liter, has been associated in scientific literature with effects on the immune system, thyroid function, and reproductive health. These are not acute poisoning symptoms but chronic, systemic effects that accumulate over years of exposure.
Consumers purchasing products manufactured with PFAS coatings or materials have historically received no warning that their food containers, clothing, or furniture could contribute to these health effects. The absence of warning labels on PFAS-containing products is a central focus of New York’s lawsuit and represents a gap in consumer autonomy. Someone purchasing water-resistant outdoor gear or non-stick cookware has no way to know, based on product labeling, that these items will eventually release PFAS into the environment and potentially into their own bodies through water contamination. This information asymmetry—where companies possessed knowledge of risks but consumers did not—forms the legal basis for the failure-to-warn claims.
Court Remedies and Long-Term Implications
The relief New York seeks through the lawsuit—environmental cleanup funding, mandatory warning labels, financial penalties, and prohibition on future sales without warnings—represents a comprehensive approach to preventing both past harm and future exposure. If successful, court orders requiring cleanup could redirect company resources toward remediating the estimated 68 percent of wells near inactive landfills that now contain PFAS. The mandate for warning labels would shift market dynamics by allowing consumers to choose whether to purchase products with known PFAS content, fundamentally altering the risk-benefit calculation that has favored these chemicals for decades.
The lawsuit also acknowledges that financial damages alone cannot undo environmental contamination. A court order requiring companies to fund cleanup efforts statewide addresses the reality that contamination now pervades 50 percent of New York’s public water systems, and that trend will not reverse without sustained intervention. The prohibition on selling PFAS-containing products without adequate warnings would prevent the introduction of new contamination from future sales, stopping the cycle that has allowed these chemicals to accumulate for 50 years. The case is pending before New York State Supreme Court in Albany County.
- —